您的位置: 首页 > 2020年3月 第51卷 第2期 > 文字全文
2023年7月 第38卷 第7期11
目录

融合基因阳性急性B淋巴细胞白血病患儿免疫表型分析

Analysis of immunophenotype of children with acute B-lymphoblastic leukemia carrying fusion gene

来源期刊: 广州医药 | 40-44 发布时间:2021-11-28 收稿时间:2025/11/13 17:53:03 阅读量:57
作者:
关键词:
急性B淋巴细胞白血病融合基因流式细胞术免疫表型
Acute B-lymphoblastic leukemiaFusion geneFlow cytometryImmunophenotype
DOI:
10.3969/j.issn.1000-8535.2020.02.009
收稿时间:
2019-09-15 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 通过对43种融合基因在儿童白血病中的结果分析,探讨融合基因阳性的儿童急性B淋巴细胞白血病(acute B-lymphoblastic leukemia,B-ALL)的免疫表型特征。方法 应用实时荧光探针PCR法对2016年10月—2018年12月在深圳市儿童医院就诊的初发或复发B-ALL患儿进行融合基因检测,采用多参数流式细胞术(flow cytometry,FCM)对B-ALL患者进行免疫表型检测。结果 120例B-ALL患儿融合基因筛选总阳性率为37.5%(45/127),包括TEL/AML1 27例、E2 A/PBX1 7例、BCR/ABL1 6例、MLL 4例、TLS/ERG 1例;不同年龄段白血病融合基因阳性率差异有统计学意义(P<0.01),性别分布差异无统计学意义(P>0.05)。各融合基因阳性组CD19阳性率为100%,TEL/AML1阳性表达患者普通-B-ALL表型占比最高(77.8%),干/祖细胞抗原CD34的阳性率为81.5%;E2 A/PBX1阳性表达患者以前-B-ALL表型为主,不表达已知的T系及髓系抗原;各融合基因阳性组及阴性组患儿髓系抗原阳性率比较差异有统计学意义(P<0.01),以BCR/ABL1基因表达组阳性率最高(100%)。结论 5种融合基因在患者年龄构成及免疫表型中具有一定的分布特点;B-ALL特征性免疫表型的改变可用于融合基因表达的预测,提高融合基因结果判读的准确率。
Objective To investigate the immunophenotype features of children with acute B-lymphoblastic leukemia(B-ALL) combined with fusion gene expressing after to analyze the results of the 43 fusion genes. Methods Real-time fluorescent probe PCR assay was used for the detection of fusion genes in 120 cases of children from Shenzhen Children's Hospital with B-ALL newly or recurrently diagnosed from Oct 2016 to Dec 2018. Multi-parameter flow cytometry(FCM) was used for the detection of the immunophenotype in children with B-ALL. Results Of all the 120 cases, the fusion genes were detected at positive rate of 37.5%(45/120), included TEL/AML1 27 cases, E2 A/PBX1 7 cases, BCR/ABL1 6 cases, MLL 4 cases, TLS/ERG 1 cases. The positive rate of leukemia fusion gene had statistically difference among fusion genes positive groups based on age(P<0.01). There was no statistically difference in the gender distribution(P>0.05). The expressing of CD19 was at positive rate of 100% in all of the groups. The rate of the common-B-ALL was the highest B-ALL subtype in the TEL/AML1 positive groups(77.8%). The stem /progenitor associated antigen CD34 was at positive rate of 81.5%. The pre-B-ALL was the main subtype in the E2 A/PBX1 group, which was no expression of the known T-ALL associated antigen MyAg antigen. There was statistically difference in the positive rate of MyAg expression among all of the groups(P<0.01), with the highest rate in the BCR/ABL1 group(100%). Conclusion There were certain distribution features in age composition and immunophenotype of children with B-ALL carrying five kinds of common fusion genes. The characteristic changes of the immunophenotype of B-ALL may be used to predict the expression of fusion genes and improve the accuracy of fusion genes by the supplementary role of immunophenotype analysis.
1、 VITALE A, GUARINI A, ARIOLA C, et al. Adult T cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMALAL 496 protocol[J]. Blood, 2006, 107(2): 473-479. VITALE A, GUARINI A, ARIOLA C, et al. Adult T cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMALAL 496 protocol[J]. Blood, 2006, 107(2): 473-479.
2、 刘芳,高丽,于力. 急性淋巴细胞白血病融合基因研究进展[J]. 中华保健医学杂志,2013,15(1):70-72. 刘芳,高丽,于力. 急性淋巴细胞白血病融合基因研究进展[J]. 中华保健医学杂志,2013,15(1):70-72.
3、 徐一卓,王西阁,陈力溶. 河南地区248例儿童急性淋巴细胞白血病融合基因类型分析[J]. 郑州大学学报(医学版),2019,54(3):470-473. 徐一卓,王西阁,陈力溶. 河南地区248例儿童急性淋巴细胞白血病融合基因类型分析[J]. 郑州大学学报(医学版),2019,54(3):470-473.
4、 JIANG Z, DENG M, WEI X, et al. Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized[J]. J Hematol Oncol, 2016, 9(1) : 94-101. JIANG Z, DENG M, WEI X, et al. Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized[J]. J Hematol Oncol, 2016, 9(1) : 94-101.
5、 唐燕萍,蔡政民,唐亚梅, 等. 表达融合基因的急性B淋巴细胞白血病患者形态学和免疫表型特点[J]. 现代肿瘤医学,2017,25(7):1097-1100. 唐燕萍,蔡政民,唐亚梅, 等. 表达融合基因的急性B淋巴细胞白血病患者形态学和免疫表型特点[J]. 现代肿瘤医学,2017,25(7):1097-1100.
6、 谢淑佩,段炤,陈媛媛,等. TEL-AML1融合基因的表达与儿童急性淋巴细胞白血病的疗效及预后相关性研究[J]. 海南医学,2012,23(22):4-6. 谢淑佩,段炤,陈媛媛,等. TEL-AML1融合基因的表达与儿童急性淋巴细胞白血病的疗效及预后相关性研究[J]. 海南医学,2012,23(22):4-6.
7、 张建平,杨君芳,王芳,等. 1 392例初诊儿童急性淋巴细胞白血病患者36种融合基因筛查分析[J]. 临床与病理杂志,2018,38(5):956-959. 张建平,杨君芳,王芳,等. 1 392例初诊儿童急性淋巴细胞白血病患者36种融合基因筛查分析[J]. 临床与病理杂志,2018,38(5):956-959.
8、 JIN Y, WANG X, HU S, et al. Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing[J]. Cancer Med, 2016, 5(2):337-351. JIN Y, WANG X, HU S, et al. Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing[J]. Cancer Med, 2016, 5(2):337-351.
9、 赵莉,高吉照,李艳,等. 50例儿童急性淋巴细胞白血病免疫分型、染色体核型及融合基因与预后分析[J]. 中国小儿血液与肿瘤杂志,2019,24(2):95-99. 赵莉,高吉照,李艳,等. 50例儿童急性淋巴细胞白血病免疫分型、染色体核型及融合基因与预后分析[J]. 中国小儿血液与肿瘤杂志,2019,24(2):95-99.
10、 贺晶,刘伶. NUDT15基因型对儿童急性淋巴细胞白血病6-MP个体化治疗的影响[J]. 中国当代儿科杂志,2019,21(1):100-104. 贺晶,刘伶. NUDT15基因型对儿童急性淋巴细胞白血病6-MP个体化治疗的影响[J]. 中国当代儿科杂志,2019,21(1):100-104.
11、 BING C, LU J, MENGLING Z, et al. Identification of fusion genes and characterization of transcriptomeeature in T-cell Acute Lymphoblastic Leukemia[J]. Proc Natl Acad Sci USA, 2018, 115(2):373-378. BING C, LU J, MENGLING Z, et al. Identification of fusion genes and characterization of transcriptomeeature in T-cell Acute Lymphoblastic Leukemia[J]. Proc Natl Acad Sci USA, 2018, 115(2):373-378.
12、 陈晓娟,邹尧,刘晓明,等. CCLLG-ALL2008方案治疗不同分子生物学特征儿童急性淋巴细胞白血病的长期疗效分析[J]. 中国当代儿科杂志,2019,21(9):890-893. 陈晓娟,邹尧,刘晓明,等. CCLLG-ALL2008方案治疗不同分子生物学特征儿童急性淋巴细胞白血病的长期疗效分析[J]. 中国当代儿科杂志,2019,21(9):890-893.
13、 中华医学会儿科学分会血液学组,中华儿科杂志编辑委员会.儿童急性淋巴细胞白血病诊疗建议(第四次修订草案) [J]. 中华儿科杂志,2014,52(9):641-644. 中华医学会儿科学分会血液学组,中华儿科杂志编辑委员会.儿童急性淋巴细胞白血病诊疗建议(第四次修订草案) [J]. 中华儿科杂志,2014,52(9):641-644.
14、 JALAL S D, AI-ALLAWI NAS, AI DOSKI AA S. Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients [J]. Int J Lab Hematol, 2017, 39(6):625-632. JALAL S D, AI-ALLAWI NAS, AI DOSKI AA S. Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients [J]. Int J Lab Hematol, 2017, 39(6):625-632.
15、 罗源,王春美,盛光耀. 复发儿童急性淋巴细胞白血病58例临床分析[J]. 中国小儿血液与肿瘤杂志,2016,21(4):201-206. 罗源,王春美,盛光耀. 复发儿童急性淋巴细胞白血病58例临床分析[J]. 中国小儿血液与肿瘤杂志,2016,21(4):201-206.
16、 WICKENHAUSER C. WHO classification of myeloid neoplasms[J]. Pathol, 2018,39(12):315-318. WICKENHAUSER C. WHO classification of myeloid neoplasms[J]. Pathol, 2018,39(12):315-318.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录